TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32533792

Group type: EXPERIMENTAL
Intervention: Propranolol and etodolac (COX2-inhibitor) administered for 20 perioperative days, starting 5 days before surgery.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo group (control).
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Propranolol and etodolac (treatment group).
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Propranolol and etodolac (treatment group, protocol-compliant patients).
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo group (control, protocol-compliant patients).
Number of subjects: 34
Study: 35768774

Group type: EXPERIMENTAL
Intervention: Endurance training (treadmill running at 15-20 m/min for 60 min, 5 days/week for 5 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sedentary (control group)
Number of subjects: 0
Study: 33831649

Group type: COMPARATOR
Intervention: Electronic seizure diary (e-diary)
Number of subjects: 66
Study: 35946217

Group type: EXPERIMENTAL
Intervention: Air Q
Number of subjects: 91

Group type: COMPARATOR
Intervention: ILMA
Number of subjects: 91
Study: 33543655

Group type: EXPERIMENTAL
Intervention: Melatonin (18 mg/day) from 1 week before until 1 month after adjuvant radiotherapy
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 33024339

Group type: EXPERIMENTAL
Intervention: Stationary training with reminder (text message)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Distance learning with reminder (text message)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Stationary training
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Distance learning
Number of subjects: 320
Study: 36282988

Group type: EXPERIMENTAL
Intervention: Ibudilast
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 34446682

Group type: EXPERIMENTAL
Intervention: Preventive interventions in occupational health (OH)
Number of subjects: 3428

Group type: EXPERIMENTAL
Intervention: Randomised controlled trials (RCTs) of preventive interventions
Number of subjects: 3428

Group type: EXPERIMENTAL
Intervention: Systematic reviews of preventive interventions
Number of subjects: 3428
Study: 32092084

Group type: EXPERIMENTAL
Intervention: Op-Ed article about political probity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34491543

Group type: EXPERIMENTAL
Intervention: Sodium nitrite infusion for 1 hour
Number of subjects: 33

Group type: COMPARATOR
Intervention: Saline infusion for 1 hour
Number of subjects: 33
Study: 35317772

Group type: EXPERIMENTAL
Intervention: AFFIRM intervention (awareness of reduced fetal movements and care pathway)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 35010998

Group type: EXPERIMENTAL
Intervention: Dihydroberberine 100 mg (D100)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Dihydroberberine 200 mg (D200)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Berberine 500 mg (B500)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 5
Study: 36379612

Group type: EXPERIMENTAL
Intervention: Two-stage regional citrate anticoagulation (RCA) with 0.04 g/mL sodium citrate infusion for 3 hours during dialysis
Number of subjects: 159

Group type: COMPARATOR
Intervention: Saline flushing
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Two-stage regional citrate anticoagulation (RCA)
Number of subjects: 159
Study: 32484415

Group type: EXPERIMENTAL
Intervention: Multiphase Menon score
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Single-phase Menon score
Number of subjects: 119

Group type: COMPARATOR
Intervention: CT perfusion parameters
Number of subjects: 119
Study: 35182393

Group type: EXPERIMENTAL
Intervention: Mindfulness-based Cognitive Therapy (MBCT)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Focused Attention (FA)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Open Monitoring (OM)
Number of subjects: 89
Study: 32656770

Group type: EXPERIMENTAL
Intervention: Experimental group (awareness of diagnostic label)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (non-awareness of label)
Number of subjects: 120
Study: 33413942

Group type: EXPERIMENTAL
Intervention: Calcium chloride (CaCl2) injection (2 ml of 5%) into the major atrial ganglionated plexi during CABG
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sodium chloride (0.9%) injection (sham control) into the major atrial ganglionated plexi during CABG
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Calcium chloride (CaCl2) injection
Number of subjects: 200
Study: 34545949

Group type: EXPERIMENTAL
Intervention: Luseogliflozin (SGLT2 inhibitor)
Number of subjects: 0
Study: 33623076

Group type: EXPERIMENTAL
Intervention: nabiximols
Number of subjects: 27

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 27
Study: 33465767

Group type: EXPERIMENTAL
Intervention: Omega-3 long-chain polyunsaturated fatty acids (LCPUFAs) supplementation
Number of subjects: 5544
Study: 35125737

Group type: EXPERIMENTAL
Intervention: Immediate Postplacental (PP) group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immediate Postabortal (PA) group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interval (INT) group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cumulative expulsion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cumulative removal
Number of subjects: 0
Study: 32369571

Group type: EXPERIMENTAL
Intervention: Encode protocol
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional protocol
Number of subjects: 47
Study: 32001517

Group type: EXPERIMENTAL
Intervention: TennisReady (e-health prevention programme)
Number of subjects: 579

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: High adherent group
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: Low adherent group
Number of subjects: 579
Study: 32483061

Group type: EXPERIMENTAL
Intervention: Eccentric training (twice-weekly for 6 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (standard in-season regimen)
Number of subjects: 20
Study: 33057936

Group type: EXPERIMENTAL
Intervention: 8 mmHg pneumoperitoneum
Number of subjects: 201

Group type: COMPARATOR
Intervention: 12 mmHg pneumoperitoneum
Number of subjects: 201
Study: 32460786

Group type: EXPERIMENTAL
Intervention: ARCHES intervention (treatment condition)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-of-care contraceptive counseling (control condition)
Number of subjects: 0
Study: 35502575

Group type: EXPERIMENTAL
Intervention: Pridinol (PRI)
Number of subjects: 342

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 342
Study: 34092636

Group type: EXPERIMENTAL
Intervention: Continuous transcranial photobiomodulation (c-tPBM) with near-infrared radiation (830 nm; 54.8 mW/cm2; 65.8 J/cm2; 2.3 kJ)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham transcranial photobiomodulation (s-tPBM)
Number of subjects: 10
Study: 32384205

Group type: EXPERIMENTAL
Intervention: 577-nm high-power optically pumped semiconductor laser (HOPSL) treatment
Number of subjects: 21

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 21
Study: 83186811

Group type: EXPERIMENTAL
Intervention: Electroconditioning aversion program with vodka
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Electroconditioning aversion program with preferred beverage
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Electroconditioning aversion program with both shock and covert sensitization
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Internals and hard liquor drinkers
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Field dependency
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Non-preferred beverage
Number of subjects: 47
Study: 34268566

Group type: EXPERIMENTAL
Intervention: Home-based resistance exercises co-designed by group discussion contributors (mean age 75, 61% female)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Dietary guidance and patient communication co-designed in workshops (mean age 71, 60% females)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Frailty intervention format and GP follow-up shaped in telephone interviews (mean age 77, 63% female)
Number of subjects: 112
Study: 34032204

Group type: COMPARATOR
Intervention: Daclatasvir hydrochloride tablets (60 mg) under fasting conditions
Number of subjects: 72

Group type: COMPARATOR
Intervention: Daclatasvir hydrochloride tablets (60 mg) under postprandial conditions
Number of subjects: 72
Study: 36207891

Group type: COMPARATOR
Intervention: Caloric restriction (CR)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Rope-skipping exercise (RS)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Caloric restriction combined with rope-skipping exercise (CR-RS)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Control group (CT)
Number of subjects: 29
Study: 33536253

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 70

Group type: COMPARATOR
Intervention: Intensive insulin only (Control)
Number of subjects: 70
Study: 33485162

Group type: EXPERIMENTAL
Intervention: High-fidelity clinical simulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 0
Study: 35690997

Group type: EXPERIMENTAL
Intervention: AH8 10% lotion formulated in Cetaphil Moisturizing Facial Lotion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control vehicle lotion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.00005% AH8
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.0005% AH8
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.005% AH8
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.025% AH8
Number of subjects: 0
Study: 33667308

Group type: EXPERIMENTAL
Intervention: 50% Nitrous oxide (N2O)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Medical air
Number of subjects: 80
Study: 35001901

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-rebreather mask (NRBM)
Number of subjects: 0
Study: 34099004

Group type: EXPERIMENTAL
Intervention: Facilitated implementation (external facilitation)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Minimal implementation support
Number of subjects: 25
Study: 36437993

Group type: EXPERIMENTAL
Intervention: Probiotic intervention for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 0
Study: 34655393

Group type: EXPERIMENTAL
Intervention: Bipolar vessel sealing system
Number of subjects: 68

Group type: COMPARATOR
Intervention: Silk ligation of lymphatic vessels
Number of subjects: 68
Study: 35643956

Group type: EXPERIMENTAL
Intervention: Tofacitinib
Number of subjects: 83295

Group type: COMPARATOR
Intervention: TNFi
Number of subjects: 83295

Group type: COMPARATOR
Intervention: ORAL Surveillance trial
Number of subjects: 83295
Study: 33881472

Group type: EXPERIMENTAL
Intervention: Cyclic nigerosylnigerose (CNN)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Fructooligosaccharide (FOS)
Number of subjects: 13
Study: 32130716

Group type: EXPERIMENTAL
Intervention: Consumption of municipal water
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Contact with someone with acute gastroenteritis
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Contact with a child in daycare
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Being less than 35 years of age
Number of subjects: 140

Group type: COMPARATOR
Intervention: Drinking water from a private artesian well
Number of subjects: 140
Study: 34878695

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Intervention (CBI)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Supportive Intervention (SI)
Number of subjects: 92
Study: 33932799

Group type: EXPERIMENTAL
Intervention: LSFD + DP
Number of subjects: 62

Group type: COMPARATOR
Intervention: LSFD
Number of subjects: 62
Study: 32655950

Group type: EXPERIMENTAL
Intervention: NIV-NAVA
Number of subjects: 22

Group type: COMPARATOR
Intervention: NIV-PSV
Number of subjects: 22
Study: 36300839

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 1267

Group type: COMPARATOR
Intervention: Commercial Program 12 weeks (CP12)
Number of subjects: 1267

Group type: COMPARATOR
Intervention: Commercial Program 52 weeks (CP52)
Number of subjects: 1267
Study: 34483329

Group type: EXPERIMENTAL
Intervention: Arm ergometer exercise in hot and humid environment (60% peak power output for 60 min)
Number of subjects: 18
Study: 36433662

Group type: EXPERIMENTAL
Intervention: Bioactive collagen peptides (CP) 15 g daily
Number of subjects: 39
Study: 34347775

Group type: EXPERIMENTAL
Intervention: Sociodemographic predictors (female sex, higher education)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Flight-related predicting factors (variability of traumatic events)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Mental health stigma
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Post-migration factors (low income, lack of social support, low life satisfaction, strong connection to Syria)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Somatization
Number of subjects: 133
Study: 32665999

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg
Number of subjects: 58

Group type: COMPARATOR
Intervention: Alpha-adrenoreceptor blocker only (Control)
Number of subjects: 58
Study: 35366393

Group type: EXPERIMENTAL
Intervention: Combined social communication therapy at home and in education
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32508977

Group type: EXPERIMENTAL
Intervention: Disposable infusion needles with a separation‐free safety tube
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional infusion needles
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 34928192

Group type: EXPERIMENTAL
Intervention: Clinical hypnosis
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 32197911

Group type: EXPERIMENTAL
Intervention: Tian‐Tian 120 outdoor program (120 minutes outdoors daily)
Number of subjects: 1200000

Group type: COMPARATOR
Intervention: Pre-intervention period (2001-2011)
Number of subjects: 1200000

Group type: EXPERIMENTAL
Intervention: Post-intervention trend analysis
Number of subjects: 1200000

Group type: COMPARATOR
Intervention: Pre-intervention trend analysis
Number of subjects: 1200000
Study: 35789065

Group type: EXPERIMENTAL
Intervention: Ultrasonic-activated irrigation (UI)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Diode laser (LI)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Manual irrigation (Control)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Surfactant subgroups (2.5% NaOCl irrigant and ChlorCid™️ Surf)
Number of subjects: 42
Study: 33720069

Group type: EXPERIMENTAL
Intervention: Nivolumab added to first-line chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pembrolizumab added to first-line chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant nivolumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pertuzumab and trastuzumab added to perioperative FLOT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan
Number of subjects: 0
Study: 32914653

Group type: EXPERIMENTAL
Intervention: Real-world evidence (RWE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized clinical trials (RCTs)
Number of subjects: 0
Study: 35149701

Group type: EXPERIMENTAL
Intervention: Gabapentin (300 mg oral) and Methylprednisolone (125 mg IV)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 33556153

Group type: EXPERIMENTAL
Intervention: Motivational intervention model
Number of subjects: 12
Study: 34935050

Group type: EXPERIMENTAL
Intervention: Self-administered electrotherapy treatment using the Exopulse Mollii Suit®
Number of subjects: 15
Study: 34863272

Group type: EXPERIMENTAL
Intervention: Low-magnitude high-frequency vibration (LMHFV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LMHFV
Number of subjects: 0
Study: 36327101

Group type: EXPERIMENTAL
Intervention: Netarsudil once a day (QD)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Netarsudil twice a day (BID)
Number of subjects: 40
Study: 32595142

Group type: EXPERIMENTAL
Intervention: 60 mL 0.25% ropivacaine divided into four injections (two for TAP and two for RS block)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Normal saline in the same manner as the intervention group
Number of subjects: 150
Study: 34398206

Group type: EXPERIMENTAL
Intervention: Empowered relief
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Health Education
Number of subjects: 263
Study: 32500519

Group type: EXPERIMENTAL
Intervention: Tight and revealing athletic clothing (TR group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Loose and concealing athletic clothing (LC group)
Number of subjects: 80
Study: 36286602

Group type: EXPERIMENTAL
Intervention: Zolmitriptan nasal spray (ZNS) high dose
Number of subjects: 373

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 373
Study: 33388411

Group type: EXPERIMENTAL
Intervention: Ring on anastomosis (ROA)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 119
Study: 32090389

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR), 8-week program, n=15
Number of subjects: 28

Group type: COMPARATOR
Intervention: Support group with relaxation education materials, n=13
Number of subjects: 28
Study: 35306189

Group type: EXPERIMENTAL
Intervention: Interactive virtual reality (VR) play intervention including instructional play and emotional catharsis play sessions
Number of subjects: 134

Group type: COMPARATOR
Intervention: Educational photo book about intravenous placement
Number of subjects: 134
Study: 33887343

Group type: EXPERIMENTAL
Intervention: Pacing ON (DDD‐CLS mode)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Pacing OFF (ODO mode)
Number of subjects: 103
Study: 33201144

Group type: EXPERIMENTAL
Intervention: Multilayered polyurethane foam dressing applied within 24 hours of hospital admission
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard preventive pressure injury care
Number of subjects: 68
Study: 36207226

Group type: EXPERIMENTAL
Intervention: Noninvasive sacral neuromodulation (SNM) for 12 weeks
Number of subjects: 59

Group type: COMPARATOR
Intervention: Conventional treatment for 12 weeks
Number of subjects: 59
Study: 34134758

Group type: EXPERIMENTAL
Intervention: Enriched Garden (EG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional Sensory Garden (CSG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 120
Study: 36397219

Group type: EXPERIMENTAL
Intervention: Low-dose acupuncture (3 times each chemotherapy cycle for a total of 9 times)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: High-dose acupuncture (7 times each chemotherapy cycle for a total of 21 times)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (conventional chemotherapy and antiemetic treatment)
Number of subjects: 58
Study: 32900325

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 1513

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1513
Study: 34281312

Group type: EXPERIMENTAL
Intervention: CGF-WP (White Part)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: CGF-BC (Buffy Coat)
Number of subjects: 4

Group type: COMPARATOR
Intervention: CTR (Control - natural healing)
Number of subjects: 4
Study: 34339562

Group type: EXPERIMENTAL
Intervention: Intervention group 1 (age-targeted messages)
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Intervention group 2 (age-targeted messages)
Number of subjects: 825

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 825
Study: 33229455

Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 35732399

Group type: EXPERIMENTAL
Intervention: Intraperitoneal paclitaxel monotherapy, administered through a peritoneal port-a-cath (PAC) system, with 8-16 weekly cycles.
Number of subjects: 0
Study: 33406254

Group type: EXPERIMENTAL
Intervention: Higher sleep fragmentation index
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Greater wake after sleep onset
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Lower percent sleep
Number of subjects: 615
Study: 32275690

Group type: EXPERIMENTAL
Intervention: Interferon α1b nebulization
Number of subjects: 0
Study: 34952973

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided saline enema with intestinal fluid drained after 15 minutes of intestinal pressure maintenance (intervention group)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Ultrasound-guided saline enema with intestinal fluid drained immediately (control group)
Number of subjects: 231
Study: 34302324

Group type: EXPERIMENTAL
Intervention: Anlotinib (12 mg orally once daily for 14 days every 3 weeks)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo (analogue capsule orally once daily for 14 days every 3 weeks)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Anlotinib
Number of subjects: 82
Study: 34266468

Group type: EXPERIMENTAL
Intervention: Behavioral economic implementation strategies (nudges) delivered through electronic medical record (EMR) messages to patients, clinicians, or both.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral economic implementation strategies (nudges)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semi-structured interviews
Number of subjects: 0
Study: 35621222

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 13885

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 13885
Study: 36306479

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg once every 3 weeks for 35 cycles
Number of subjects: 1274

Group type: COMPARATOR
Intervention: Chemotherapy (carboplatin + paclitaxel or pemetrexed) for 4-6 cycles with optional maintenance pemetrexed
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: Second-course pembrolizumab
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: Pembrolizumab after 35 cycles
Number of subjects: 1274
Study: 34990498

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol 15 mg/kg before treatment (preemptive group, n = 35)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group received intravenous paracetamol 15 mg/kg at the end of treatment (control group, n = 35)
Number of subjects: 70